Brief: Anthera Pharmaceuticals agreed to sell preferred convertible stock to Biotechnology Value Fund
08/09/2016 13:32
Sept 8 (Reuters) - Anthera Pharmaceuticals Inc ANTH.O
* Agreed to sell preferred convertible stock to
Biotechnology Value Fund and other affiliates of BVF Partners,
and Rock Springs Capital
* Anthera Pharmaceuticals says sale of the stock in two
tranches for initial proceeds of $17 million with option for
additional $28.33 million
Source text for Eikon: ID:nGNXNBWOSa
Further company coverage: ANTH.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Anthera Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Micron, Darden, Kroger, American Outdoor
Brief: Anthera Pharma's Board Approves Personnel Reorganization Plan
U.S. STOCKS ON THE MOVE-Anthera, Oclaro, Intel, Broadcom, Netflix, BlueLinx, Micron
U.S. STOCKS ON THE MOVE-Anthera, Oclaro, Intel, Broadcom, BlueLinx, Orexigen, Micron
U.S. STOCKS ON THE MOVE-Anthera, Oclaro, Intel, Broadcom, Orexigen, Goldman